QQC:CA:TSX-Invesco NASDAQ 100 Index ETF CAD Units (CAD)

ETF | US Equity |

Last Closing

CAD 37

Change

+0.32 (+0.87)%

Market Cap

N/A

Volume

0.13M

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-01-30 )

Largest Industry Peers for US Equity

Symbol Name Price(Change) Market Cap
VFV:CA Vanguard S&P 500 Index ETF

+1.46 (+0.94%)

CAD 21.68B
ZSP:CA BMO S&P 500

+0.89 (+0.93%)

CAD 19.55B
XSP:CA iShares Core S&P 500 (CAD Hedg..

+0.35 (+0.56%)

CAD 12.06B
VUN:CA Vanguard US Total Market

+1.23 (+1.05%)

CAD 11.46B
XUS:CA iShares Core S&P 500 Index ETF

+0.49 (+0.91%)

CAD 8.74B
HXS:CA Global X S&P 500 Corporate Cla..

+0.32 (+0.36%)

CAD 4.79B
VSP:CA Vanguard S&P 500 CAD hedged

+0.45 (+0.46%)

CAD 4.16B
XUU:CA iShares Core S&P US Total Mark..

+0.61 (+0.95%)

CAD 3.50B
QUU:CA Mackenzie US Large Cap Equity ..

+2.21 (+0.88%)

CAD 3.48B
XQQ:CA iShares NASDAQ 100 (CAD Hedged..

+0.22 (+0.41%)

CAD 3.42B

ETFs Containing QQC:CA

N/A

Market Performance

  Market Performance vs. Industry/Classification (US Equity) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 3.18% 36% F 61% D-
Dividend Return N/A N/A N/A N/A N/A
Total Return 3.18% 34% F 61% D-
Trailing 12 Months  
Capital Gain 33.62% 83% B 84% B
Dividend Return 0.43% 6% D- 5% F
Total Return 34.05% 80% B- 83% B
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 15.16% 76% C+ 79% B-
Dividend Return 15.23% 58% F 74% C
Total Return 0.07% 5% F 5% F
Risk Return Profile  
Volatility (Standard Deviation) 17.35% 29% F 50% F
Risk Adjusted Return 87.75% 49% F 89% A-
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (CAD)

Quarterly Financials (CAD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.